Duo co-managed the Axa Framlington global emerging markets funds
Tag: Newton
Healthcare stocks – race for a remedy
Hunt for treatments and vaccines puts spotlight on pharmaceutical companies
Risks and rewards in Russian equities
The sanctions can make investing in Russia a bumpy ride. But there are still attractive returns to be found
Trump – from asset to liability for US equities?
When Donald Trump had just been elected to the US presidency, investors believed this would power US equities to new highs, while emerging market assets were expected to suffer. Four months into his presidency, expectations have changed radically.
riding the commodity carousel
The rise in commodity prices may have peaked but does this mean the super-cycle is over, and should you buy or sell the asset class? By Manuel-Yutaro Rubio, alternative investment strategies fund analyst, Allfunds Bank
